On September 10, 2015, plaintiffs filed a new class action lawsuit against the manufacturers of diabetes drug Invokana: Janssen Pharmaceuticals and parent company Johnson & Johnson. Representative plaintiff Rosalba Joudry, a resident of Ontario, filed the case on behalf of all persons in Canada who…
In June 2014, all federal testosterone lawsuits were consolidated into one court in the Northern District of Illinois. Since then, the litigation has been growing, to the point that there are now about 2,500 cases pending. These cases involve claims concerning testosterone replacement products like…
The FDA-approved type 2 diabetes medication Invokana (canagliflozin) first came on the market in March 2013. Now, only a little over two years later, the medication has been linked to a number of dangerous side effects, including kidney failure, diabetic ketoacidosis, bone fractures, and more.…
The current testosterone MDL, which was established in June 2014, continues to grow. Over 2,400 lawsuits are pending in the Northern District of Illinois, with plaintiffs claiming that manufacturers of testosterone products like AndroGel, Testim, and Axiron failed to provide adequate warnings about
On July 17, 2015, plaintiffs from Massachusetts filed a new Zofran lawsuit in the U.S. District Court of the District of Massachusetts. They claim that after the mother took Zofran during her pregnancy, she gave birth to a baby boy who suffered from serious birth…
Though many men have been convinced by the drug manufacturers marketing that low testosterone levels should be “fixed” with gels, patches, and injections, science shows that testosterone levels natural decline as a man ages, and that lifestyle factors, as well, can influence them. And while…
All federal Xarelto lawsuits, which were consolidated into the Eastern District of Louisiana in December 2014, involve patients who took the drugs and then suffered serious side effects. According to the latest case list from the court, there are now nearly 1,700 cases pending, with…
In May 2015, the Food and Drug Administration (FDA) warned doctors and patients that certain types of type 2 diabetes drugs, including Invokana (canagliflozin), could cause diabetic ketoacidosis (DKA) in some patients. This is a serious condition in which the blood becomes too acidic, and…
Over 1,900 Xarelto lawsuits are currently pending in state and federal courts, with plaintiffs claiming that the anticoagulant caused serious injuries, including gastrointestinal bleeding, blood clots, stroke, and heart attack. Within just a couple years of being on the market, Xarelto (rivaroxaban)
The FDA released another safety warning concerning type 2 diabetes medication Invokana (canagliflozin). Back in May 2015, the administration warned doctors and patients of the potential for Invokana to increase risk of diabetic ketoacidosis (DKA), a condition in which the blood becomes too acidic. W
In April 2015, an FDA advisory panel voted to include new safety information about potential heart failure side effects on the label of the diabetes drug Onglyza (saxaglipton). This was after the panel reviewed the results of the “SAVOR” trial, in which researchers found that…
On September 1, 2015, plaintiffs filed another Zofran lawsuit in the Central District of California. Though there has been no Zofran MDL established yet, Zofran manufacturer GlaxoSmithKline (GSK) has filed a motion requesting that all federally filed Zofran lawsuits be brought together in one court…